Breaking News Instant updates and real-time market news.

PCRX

Pacira

$30.68

-0.225 (-0.73%)

, HRTX

Heron Therapeutics

$27.30

5.8 (26.98%)

08:55
03/20/18
03/20
08:55
03/20/18
08:55

Pacira price target lowered to $42 after Heron data at Seaport Global

Seaport Global analyst Corey Davis noted that Heron Therapeutics (HRTX) reported positive results from its two Phase 3 studies of HTX-011 for postoperative pain in bunionectomy and herniorrhaphy. While Heron's HTX-011 data suggest some competition in 2020 for Pacira's (PCRX) Exparel, Davis said dose and volume "present problems" and that Heron "may run into a pricing problem" as well. He reiterates his Buy rating on Pacira shares, though he lowered his price target on the stock to $42 from $50, noting that he has formally removed nerve block revenue for Exparel entirely from his model after the negative FDA AdCom last month.

PCRX

Pacira

$30.68

-0.225 (-0.73%)

HRTX

Heron Therapeutics

$27.30

5.8 (26.98%)

  • 06

    Apr

PCRX Pacira
$30.68

-0.225 (-0.73%)

02/21/18
BMOC
02/21/18
NO CHANGE
Target $32
BMOC
Market Perform
Pacira Q4 sales momentum 'eased a bit' in January, says BMO Capital
BMO Capital analyst Gary Nachman notes Symphony data for January were released and show sales of Pacira Pharmaceuticals' Exparel of $23.2M, up a "healthy" 12.4% year-over-year. While the sales dropped 14.3% from December, January is normally lighter than December, Nachman tells investors in an intraday research note. Sales per selling day were below the levels for all Q4, the analyst notes, which he views as more concerning than the month-over-month decline. The analyst believes "some of the Exparel momentum" in Q4 "eased a bit" in January. He keeps a Market Perform rating on Pacira with a $32 price target.
03/01/18
HCWC
03/01/18
NO CHANGE
Target $45
HCWC
Buy
Pacira price target lowered to $45 from $55 at H.C. Wainwright
H.C. Wainwright analyst Oren Livnat lowered his price target for Pacira Pharmaceuticals to $45 after entirely removing the nerve-block indication for Exparel. The analyst, however, views the company's 2018 outlook as conservative and keeps a Buy rating on the shares.
03/01/18
RBCM
03/01/18
NO CHANGE
Target $44
RBCM
Outperform
Pacira price target lowered to $44 from $54 at RBC Capital
RBC Capital analyst Randall Stanicky lowered his price target on Pacira to $44 after Q4 earnings, saying the outlook for FY18 EXPAREL sales was below expectations. Stanicky keeps his Outperform rating on the stock, noting that the guidance is likely conservative and leaves some room for the upside in the upcoming updates.
03/19/18
JEFF
03/19/18
NO CHANGE
Target $30
JEFF
Buy
Heron pain drug 'hits a home run' in Phase III studies, says Jefferies
Jefferies analyst Biren Amin says Heron Therapeutics's (HRTX) HTX-011 "hits a home run" by meeting all primary and key secondary endpoints this morning from Phase III trials in bunionectomy and hernia repair. Safety looked clean in both studies, and HTX-011 produced durable pain reduction up to 72 hours and significant opioid sparing effect and differentiates from generic bupivacaine, Amin tells investors in a research note. The analyst believes HTX-011 should receive a superiority claim versus generic bupivacaine in its label for both bunionectomy and hernia surgery. Amin notes that Pacira's (PCRX) Exparel does not have this claim in its label. He assumes peak sales of $545M for HTX-011 and keeps a Buy rating on Heron with $30 price target.
HRTX Heron Therapeutics
$27.30

5.8 (26.98%)

03/02/18
LEER
03/02/18
NO CHANGE
Target $29
LEER
Outperform
Leerink ups Heron Therapeutics target to $29 after competitor setback
Leerink analyst Ami Fadia raised her price target for Heron Therapeutics (HRTX) to $29 from $27 after Tesaro (TSRO) announced earlier this week that it has withdrawn all promotional support for IV Varubi, based on numerous reports of anaphylaxis. Heron's Cinvanti, Tesaro's Varubi and Merck's (MRK) Emend are the only three branded NK-1 antagonists in the market today for chemo induced nausea and vomiting, Fadia tells investors in a research note. With Emend expected to go generic soon, Cinvanti will be the sole marketed branded agent, the analyst adds. She increased her 2023 estimate for Cinvanti from $150M to just under $200M and keeps an Outperform rating on Heron Therapeutics. The analyst continues to see upside for the stock ahead of the two Phase 3 trials for HTX-011 expected to read out in Q2.
03/20/18
MZHO
03/20/18
NO CHANGE
Target $35
MZHO
Buy
Heron Therapeutics price target raised to $35 from $28 at Mizuho
Mizuho analyst Difei Yang raised her price target for Heron Therapeutics to $35 citing yesterday's positive data from HTX-011 in two Phase 3 studies. The results demonstrate the superior product profile of HTX-011 in post-operative pain management compared to the current standard of care, Yang tells investors in a research note. She keeps a Buy rating on Heron shares.
03/20/18
NEED
03/20/18
NO CHANGE
Target $42
NEED
Buy
Heron Therapeutics price target raised to $42 from $30 at Needham
Needham analyst Serge Belanger raised his price target on Heron Therapeutics to $42 after the company's phase 3 trial results for HTX-011 on post-surgical pain management. The analyst says the treatment met all the primary and secondary endpoints while also demonstrating superiority over placebo and bupivacaine in terms of pain relief and opioid consumption. Belanger keeps his Buy rating on Heron Therapeutics, adding that the HTX-011 could be "game changer", with NDA filing coming in the second half of this year.

TODAY'S FREE FLY STORIES

03:10
10/16/18
10/16
03:10
10/16/18
03:10
General news
FX Action: USD-CAD has settled near 1.3000 »

FX Action: USD-CAD has…

02:40
10/16/18
10/16
02:40
10/16/18
02:40
General news
FX Update: Most Dollar pairings have been steady »

FX Update: Most Dollar…

01:30
10/16/18
10/16
01:30
10/16/18
01:30
General news
Asian Market Wrap: »

Asian Market Wrap:…

22:45
10/15/18
10/15
22:45
10/15/18
22:45
General news
China's CPI grew 2.5% y/y in September »

China's CPI grew…

PYPL

PayPal

$77.22

-1.8 (-2.28%)

20:49
10/15/18
10/15
20:49
10/15/18
20:49
Recommendations
PayPal analyst commentary at Stifel »

PayPal earnings to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 22

    Oct

  • 13

    Nov

  • 26

    Nov

ALRM

Alarm.com

$44.50

0.16 (0.36%)

20:45
10/15/18
10/15
20:45
10/15/18
20:45
Upgrade
Alarm.com rating change at First Analysis »

Alarm.com upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

SGBAF

SES S.A.

$0.00

(0.00%)

20:36
10/15/18
10/15
20:36
10/15/18
20:36
Upgrade
SES S.A. rating change at JPMorgan »

SES S.A. upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$133.75

-0.03 (-0.02%)

, UNH

UnitedHealth

$259.80

0.36 (0.14%)

20:25
10/15/18
10/15
20:25
10/15/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

JNJ

Johnson & Johnson

$133.75

-0.03 (-0.02%)

UNH

UnitedHealth

$259.80

0.36 (0.14%)

GS

Goldman Sachs

$215.28

1.37 (0.64%)

MS

Morgan Stanley

$43.45

(0.00%)

BLK

BlackRock

$427.40

-0.18 (-0.04%)

PLD

Prologis

$63.00

0.45 (0.72%)

PGR

Progressive

$66.23

-0.64 (-0.96%)

GWW

Grainger

$318.38

6.75 (2.17%)

OMC

Omnicom

$69.48

0.8 (1.16%)

CMA

Comerica

$83.69

-1.04 (-1.23%)

JBHT

J.B. Hunt

$111.78

2.52 (2.31%)

DPZ

Domino's Pizza

$273.13

-4.215 (-1.52%)

FHN

First Horizon

$15.99

-0.11 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 24

    Oct

  • 26

    Oct

  • 28

    Oct

  • 05

    Nov

  • 06

    Nov

  • 27

    Nov

  • 24

    Jan

TWLO

Twilio

$76.26

1.27 (1.69%)

, SEND

SendGrid

$30.94

0.04 (0.13%)

20:13
10/15/18
10/15
20:13
10/15/18
20:13
Recommendations
Twilio, SendGrid analyst commentary at MUFG »

MUFG analyst 'fully…

TWLO

Twilio

$76.26

1.27 (1.69%)

SEND

SendGrid

$30.94

0.04 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

PANW

Palo Alto Networks

$209.49

-2.51 (-1.18%)

20:07
10/15/18
10/15
20:07
10/15/18
20:07
Recommendations
Palo Alto Networks analyst commentary at JPMorgan »

Palo Alto Networks'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 10

    Dec

SVA

Sinovac Biotech

$7.16

-0.03 (-0.42%)

20:03
10/15/18
10/15
20:03
10/15/18
20:03
Hot Stocks
Sinovac Biotech commences legal proceedings in Hong Kong »

Senior management of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NWN

Northwest Natural Gas

$67.70

0.36 (0.53%)

20:01
10/15/18
10/15
20:01
10/15/18
20:01
Hot Stocks
Northwest Natural Water unit to buy Sunriver Water LLC, terms not stated »

NW Natural Water Company,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

VFC

VF Corp.

$87.65

0.11 (0.13%)

19:53
10/15/18
10/15
19:53
10/15/18
19:53
Initiation
VF Corp. initiated at Wedbush »

VF Corp. initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

LVS

Las Vegas Sands

$55.84

-0.32 (-0.57%)

19:39
10/15/18
10/15
19:39
10/15/18
19:39
Upgrade
Las Vegas Sands rating change at HSBC »

Las Vegas Sands upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OXY

Occidental Petroleum

$72.24

-4.69 (-6.10%)

19:37
10/15/18
10/15
19:37
10/15/18
19:37
Recommendations
Occidental Petroleum analyst commentary at MUFG »

Occidental Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

AVMXY

Avita Medical

$0.00

(0.00%)

19:24
10/15/18
10/15
19:24
10/15/18
19:24
Hot Stocks
Avita Medical announces Recell trial results presentation »

AVITA Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$153.56

-0.2 (-0.13%)

19:16
10/15/18
10/15
19:16
10/15/18
19:16
Hot Stocks
Facebook confirms expanding policies on voter suppression »

Facebook said in a blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

JBHT

J.B. Hunt

$111.78

2.52 (2.31%)

, SEND

SendGrid

$30.94

0.04 (0.13%)

18:58
10/15/18
10/15
18:58
10/15/18
18:58
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: J.B.…

JBHT

J.B. Hunt

$111.78

2.52 (2.31%)

SEND

SendGrid

$30.94

0.04 (0.13%)

TWLO

Twilio

$76.26

1.27 (1.69%)

HQCL

Hanwah Q Cells

$8.20

-0.13 (-1.56%)

ADBE

Adobe

$238.05

-10.84 (-4.36%)

CRY

CryoLife

$30.64

0.42 (1.39%)

TRQ

Turquoise Hill

$1.96

-0.015 (-0.76%)

JELD

Jeld-Wen

$21.31

-0.04 (-0.19%)

TTOO

T2 Biosystems

$5.30

0.17 (3.31%)

ACRS

Aclaris Therapeutics

$13.38

-0.21 (-1.55%)

AGN

Allergan

$183.03

-0.275 (-0.15%)

PANW

Palo Alto Networks

$209.49

-2.51 (-1.18%)

SNAP

Snap

$7.41

0.225 (3.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 25

    Oct

  • 30

    Oct

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 27

    Nov

  • 10

    Dec

SHLD

Sears

$0.31

-0.0901 (-22.52%)

18:43
10/15/18
10/15
18:43
10/15/18
18:43
Hot Stocks
Sears receives court approval of 'first day' motions to support business ops »

Sears Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAB

Wabtec

$97.03

1.63 (1.71%)

18:38
10/15/18
10/15
18:38
10/15/18
18:38
Upgrade
Wabtec rating change at Wellington Shields »

Wabtec upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 14

    Nov

TGE

Tallgrass Energy

$23.73

0.17 (0.72%)

18:30
10/15/18
10/15
18:30
10/15/18
18:30
Hot Stocks
Tallgrass Energy, Silver Creek Midstream to expand Powder River Basin JV »

Tallgrass Energy and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIS

Disney

$113.47

0.86 (0.76%)

, GOOG

Alphabet

$1,092.00

-18.93 (-1.70%)

18:21
10/15/18
10/15
18:21
10/15/18
18:21
Hot Stocks
Disney-backed Jaunt to focus efforts on AR, says some staff will be 'moving on' »

Jaunt, a top-funded VR…

DIS

Disney

$113.47

0.86 (0.76%)

GOOG

Alphabet

$1,092.00

-18.93 (-1.70%)

GOOGL

Alphabet Class A

$1,101.58

-19.41 (-1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 07

    Nov

  • 08

    Nov

  • 03

    Mar

HMC

Honda

$27.05

-0.16 (-0.59%)

18:19
10/15/18
10/15
18:19
10/15/18
18:19
Hot Stocks
Honda to recall 54 model year 2017-2018 Honda Civic and Honda CR-V vehicles »

American Honda will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

MSFT

Microsoft

$107.60

-1.94 (-1.77%)

18:15
10/15/18
10/15
18:15
10/15/18
18:15
Hot Stocks
Microsoft co-founder Paul Allen dead at 65 »

Vulcan Inc. released…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 21

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 13

    Nov

  • 28

    Nov

  • 03

    Mar

OII

Oceaneering

$25.69

0.4 (1.58%)

18:15
10/15/18
10/15
18:15
10/15/18
18:15
Hot Stocks
Oceaneering provides update following Hurricane Michael »

Oceaneering International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.